City
Epaper

Covishield doesn't prevent mild Covid by SA variant: Govt

By IANS | Published: February 09, 2021 8:10 PM

New Delhi, Feb 9 The Union Health Ministry on Tuesday said that studies, though limited, on the variant ...

Open in App

New Delhi, Feb 9 The Union Health Ministry on Tuesday said that studies, though limited, on the variant of SARS-CoV-2 that emerged in South Africa, indicate that Covishield vaccine does not prevent mild Covid-19 disease, but continues to be effective in controlling disease severity and mortality due to the infection.

"Whatever information about the B1.351 variant of novel coronavirus we have been receiving from scientific channels is being monitored continuously. A few studies have been conducted on it. Though they are limited, but indicate that Covishield is not able to prevent the mild nature of the disease caused by the variant," Dr V.K. Paul, the head, National Covid Task Force and Member (health) of NITI Aayog, told a press conference.

"However, the vaccine continues to remain effective in controlling disease progression to severe nature as well as mortality caused by it," he added.

Paul also noted that the studies suggest that the SA variant is more transmissible. However he assured that no case of the variant has been found in the country so far.

"South Africa variant of Covid-19 is under watch. It has come forward that this variant spreads faster. As of yesterday, this particular variant is not in the country," he said.

He also informed that the country is looking forward to having multiple Covid vaccines in near future and keeping a watch over foreign vaccine candidates with a keen interest to manufacture them in India.

"There is emerging news that Sputnik V vaccine developer is tying up with industry partners here for mass manufacturing. We are also watching with great zeal the progress being made by Zydus Cadilla's vaccine candidate. Their trials are proceeding well. We have granted approval for Phase I early trial to a nasal vaccine candidate. We are watching the development in regard to Novavax's vaccine which has partnered with Serum Institute of india for production in the country. We are also keeping up with the development of Johnsons and Johnsons vaccine with an interest in manufacturing it in the country," he said.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: FebruaryNew DelhiThe Union Health MinistrySouth AfricaThe new delhi municipal councilDelhi south-west
Open in App

Related Stories

CricketT20 World Cup Squad 2024: Complete List of Teams Announced So Far

NationalSunita Kejriwal, Atishi Meet Delhi CM Arvind Kejriwal in Tihar Jail

NationalNew Delhi: A 12-Year-Old Boy Got Electrocuted After He Came in Contact With a Bombay Suburban Electric Supply

NationalHanuman Jayanti 2024: Police Security Beefed Up in Delhi’s Jahangirpuri

NationalNew Delhi: Traffic Cops Report 15 PC Drop in ‘Over-Speeding’ Violations

Health Realted Stories

HealthTB claimed 108 lives in Mizoram in 2023

HealthReducing air pollution key to fight new diabetes cases in India: Doctors

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

HealthCovaxin has excellent safety record, says Bharat Biotech

HealthDocs warn gym goers as sudden heart attacks return, killing at least 4 in 24 hrs